Roivant Sciences Ltd (ROIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,678,514 | 6,494,953 | 6,670,810 | 1,408,231 | 1,434,093 |
| Other current assets | 322,985 | 236,875 | 135,923 | 143,396 | 127,065 |
| TOTAL | $6,001,499 | $6,731,828 | $6,806,733 | $1,551,627 | $1,561,158 |
| Non-Current Assets | |||||
| PPE Net | 17,840 | 15,322 | 21,857 | 24,477 | 36,270 |
| Investments And Advances | 262,979 | 247,753 | 239,927 | 250,393 | 296,243 |
| Intangibles | 136,009 | 0 | 150,415 | 140,621 | 145,037 |
| Other Non-Current Assets | 78,121 | 227,579 | 93,747 | 98,425 | 97,938 |
| TOTAL | $494,949 | $490,654 | $505,946 | $513,916 | $575,488 |
| Total Assets | $6,496,448 | $7,222,482 | $7,312,679 | $2,065,543 | $2,136,646 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 12,000 | N/A | 45,706 | 48,998 | 44,406 |
| Accounts payable and accrued liabilities | 27,743 | 14,029 | 35,226 | 44,123 | 50,035 |
| Accrued Expenses | 138,288 | 119,417 | 122,148 | 152,923 | 119,329 |
| Other current liabilities | 27,525 | 13,941 | 31,342 | 8,599 | 19,886 |
| TOTAL | $215,045 | $266,758 | $244,899 | $265,546 | $245,004 |
| Non-Current Liabilities | |||||
| Long Term Debt | 311,716 | N/A | 403,337 | 389,445 | 385,069 |
| Other Non-Current Liabilities | 112,208 | 538,576 | 103,380 | 111,710 | 208,463 |
| TOTAL | $386,117 | $507,195 | $483,198 | $474,364 | $557,503 |
| Total Liabilities | $601,162 | $773,953 | $728,097 | $739,910 | $802,507 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 739,522 | 738,722 | 805,846 | 803,921 | 771,742 |
| Retained earnings | 671,469 | 576,172 | 727,287 | -4,368,897 | -4,064,570 |
| Other shareholders' equity | 442,029 | 475,865 | 467,035 | 374,027 | 416,799 |
| TOTAL | $5,895,286 | $6,448,529 | $6,584,582 | $1,325,633 | $1,334,139 |
| Total Liabilities And Equity | $6,496,448 | $7,222,482 | $7,312,679 | $2,065,543 | $2,136,646 |